Press Release Biocartis NV: Biocartis announces H1 2019 results

    NEXT STORY
    Drug Delivery Systems Market to hit US$ 900 billion by 2025 – TMR
    PREV STORY
    ContraFect to Present at the 2019 Janney Healthcare Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    MacroGenics Announces Closing of MGA012 Global Collaboration and License Agreement with Incyte

    ROCKVILLE, MD, Dec. 05, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    Harpoon Therapeutics Announces Changes to Board of Directors

    author_avatar
    NASDAQ Market News

    VBL Therapeutics Announces Second Quarter 2016 Financial Results and Provides Business Update

    TEL AVIV, Israel, Aug. 15, 2016 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), a clinical-stage ...

    author_avatar
    NASDAQ Market News